These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 17714766

  • 21. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N, Bootsma H, Yuvaraj S, Spijkervet FK, Haacke EA, Pollard RP, Visser A, Vissink A, Kallenberg CG, Kroese FG, Bos NA.
    Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.
    Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X, Club Rhumatismes et Inflammations and the French Society of Rheumatology.
    Ann Rheum Dis; 2013 Jun; 72(6):1026-31. PubMed ID: 23264337
    [Abstract] [Full Text] [Related]

  • 23. Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.
    Carsons SE, Vivino FB, Parke A, Carteron N, Sankar V, Brasington R, Brennan MT, Ehlers W, Fox R, Scofield H, Hammitt KM, Birnbaum J, Kassan S, Mandel S.
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):517-527. PubMed ID: 27390247
    [Abstract] [Full Text] [Related]

  • 24. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
    Wang SQ, Zhang LW, Wei P, Hua H.
    BMC Musculoskelet Disord; 2017 May 12; 18(1):186. PubMed ID: 28499370
    [Abstract] [Full Text] [Related]

  • 25. Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren's syndrome.
    Carsons SE.
    Rheum Dis Clin North Am; 2008 Nov 12; 34(4):1011-23, x. PubMed ID: 18984419
    [Abstract] [Full Text] [Related]

  • 26. Emerging drugs for primary Sjögren's syndrome.
    Gandolfo S, De Vita S.
    Expert Opin Emerg Drugs; 2019 Jun 12; 24(2):121-132. PubMed ID: 31286787
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of biological DMARDs modulating B cells in primary Sjögren's syndrome: Systematic review and meta-analysis.
    Letaief H, Lukas C, Barnetche T, Gaujoux-Viala C, Combe B, Morel J.
    Joint Bone Spine; 2018 Jan 12; 85(1):15-22. PubMed ID: 28673789
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.
    Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Seror R, Pers JO, Meiners PM, Vissink A, Bootsma H, Nowak E, Saraux A.
    Rheumatology (Oxford); 2015 Sep 12; 54(9):1699-708. PubMed ID: 25957440
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C, Pisella PJ, Brignole F.
    Rev Med Interne; 2004 May 12; 25(5):376-82. PubMed ID: 15110955
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association between memory B-cells and clinical and immunological features of primary Sjögren's syndrome and Sicca patients.
    Barcelos F, Martins C, Papoila A, Geraldes C, Cardigos J, Nunes G, Lopes T, Alves N, Vaz-Patto J, Branco J, Borrego LM.
    Rheumatol Int; 2018 Jun 12; 38(6):1063-1073. PubMed ID: 29623391
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.